Mathematical analysis of the relative contributions of decreased production and increased peripheral destruction in Idiopathic Thrombocytopenic Purpura and implications in splenectomy

Journal of Theoretical Biology

Volumn 203, Issue 2, 2000, Pages 153-162

  Hersh, Jeff ^a  

^a Brigham and Women's/Faulkner Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ANTIBODY;

ARTICLE; BONE MARROW HYPOPLASIA; HEMATOPOIESIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

PURPURA;

EID: 0034696446     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2000.1072     Document Type: Article

References (30)

1. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura
2. Glycocalcicin: A new assay - The normal plasma levels and its potential usefulness in selected diseases
3. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids
4. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP)
5. On the analysis of platelet survival curves and the calculation of platelet production and destruction
6. The relation of platelet kinetics to bone marrow megakaryocytes in chronic granulocytic leukaemia
7. Platelet turnover and megakaryocytopoesis in ITP
8. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: Insight into the regulation of platelet production
9. 51Cr-labeled platelets differ
10. Different patterns of platelet turnover in chronic idiopathic thrombocytopenic purpura
11. Platelet kinetics in patients with bone marrow hypoplasia: Evidence for a fixed platelet requirements
12. Thrombokinetics in man
13. Effects of anti-platelet glycoprotein Ib and/or IIb/IIIa autoantibodies on the size of megakaryocytes in patients with immune thrombocytopenia
14. Spectrum of Ig classes, specificities and titers of serum antiglycoprotein in chronic thrombocytopenic purpura
15. Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient
16. Effect of intravenous immunoglobulin on inhibition of fibrinogen binding to platelets by sera from patients with immune thrombocytopenia
17. Immune thrombocytopenic purpura: Autoimmune or immune complex disease?
18. Splenectomy in idiopathic thrombocytopenic purpura: Its correlation with the sequestration of autologous indium-111-labeled platelets
19. Platelet-associated complement C3 in immune thrombocytopenic purpura
20. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy
21. Platelet production in idiopathic thrombocytopenic purpura
22. Kinetics of platelets, megakaryocytes and their precursors: What to measure?
23. Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura
24. Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura
25. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia
26. Determining the lifespan of platelets labeled with 111In oxinate-first results
27. Autologous platelet kinetics in patients with severe thrombocytopenia: Discrimination between disorders of production and destruction
28. Megakaryocytes and platelets in immune thrombocytopenic purpura
29. Impaired survival of bone marrow GIIb/IIIa+ megakaryocytic cells as an additional pathogenic mechanism of HIV-1 related thrombocytopenia